These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
721 related articles for article (PubMed ID: 38270182)
1. Laryngeal mask airway surfactant administration for prevention of morbidity and mortality in preterm infants with or at risk of respiratory distress syndrome. Abdel-Latif ME; Walker E; Osborn DA Cochrane Database Syst Rev; 2024 Jan; 1(1):CD008309. PubMed ID: 38270182 [TBL] [Abstract][Full Text] [Related]
2. Surfactant therapy via thin catheter in preterm infants with or at risk of respiratory distress syndrome. Abdel-Latif ME; Davis PG; Wheeler KI; De Paoli AG; Dargaville PA Cochrane Database Syst Rev; 2021 May; 5(5):CD011672. PubMed ID: 33970483 [TBL] [Abstract][Full Text] [Related]
3. Nasal high flow therapy for primary respiratory support in preterm infants. Hodgson KA; Wilkinson D; De Paoli AG; Manley BJ Cochrane Database Syst Rev; 2023 May; 5(5):CD006405. PubMed ID: 37144837 [TBL] [Abstract][Full Text] [Related]
4. Corticosteroids for the prevention and treatment of bronchopulmonary dysplasia: an overview of systematic reviews. van de Loo M; van Kaam A; Offringa M; Doyle LW; Cooper C; Onland W Cochrane Database Syst Rev; 2024 Apr; 4(4):CD013271. PubMed ID: 38597338 [TBL] [Abstract][Full Text] [Related]
5. Prophylactic or very early initiation of continuous positive airway pressure (CPAP) for preterm infants. Subramaniam P; Ho JJ; Davis PG Cochrane Database Syst Rev; 2021 Oct; 10(10):CD001243. PubMed ID: 34661278 [TBL] [Abstract][Full Text] [Related]
6. Laryngeal mask airway surfactant administration for prevention of morbidity and mortality in preterm infants with or at risk of respiratory distress syndrome. Abdel-Latif ME; Osborn DA Cochrane Database Syst Rev; 2011 Jul; (7):CD008309. PubMed ID: 21735428 [TBL] [Abstract][Full Text] [Related]
7. Surfactant therapy guided by tests for lung maturity in preterm infants at risk of respiratory distress syndrome. Sibrecht G; Kearl CR; Borys F; Morariu M; Bruschettini M; Soll R Cochrane Database Syst Rev; 2023 Oct; 10(10):CD013158. PubMed ID: 37882216 [TBL] [Abstract][Full Text] [Related]
8. Nasal continuous positive airway pressure levels for the prevention of morbidity and mortality in preterm infants. Bamat N; Fierro J; Mukerji A; Wright CJ; Millar D; Kirpalani H Cochrane Database Syst Rev; 2021 Nov; 11(11):CD012778. PubMed ID: 34847243 [TBL] [Abstract][Full Text] [Related]
9. Inositol in preterm infants at risk for or having respiratory distress syndrome. Howlett A; Ohlsson A; Plakkal N Cochrane Database Syst Rev; 2019 Jul; 7(7):CD000366. PubMed ID: 31283839 [TBL] [Abstract][Full Text] [Related]
10. Late (≥ 7 days) systemic postnatal corticosteroids for prevention of bronchopulmonary dysplasia in preterm infants. Doyle LW; Cheong JL; Hay S; Manley BJ; Halliday HL Cochrane Database Syst Rev; 2021 Nov; 11(11):CD001145. PubMed ID: 34758507 [TBL] [Abstract][Full Text] [Related]
11. Late (≥ 7 days) inhaled corticosteroids to reduce bronchopulmonary dysplasia in preterm infants. Onland W; Offringa M; van Kaam A Cochrane Database Syst Rev; 2022 Dec; 12(12):CD002311. PubMed ID: 36521169 [TBL] [Abstract][Full Text] [Related]
12. Non-invasive high-frequency ventilation in newborn infants with respiratory distress. Abdel-Latif ME; Tan O; Fiander M; Osborn DA Cochrane Database Syst Rev; 2024 May; 5(5):CD012712. PubMed ID: 38695628 [TBL] [Abstract][Full Text] [Related]
13. Continuous positive airway pressure (CPAP) for respiratory distress in preterm infants. Ho JJ; Subramaniam P; Davis PG Cochrane Database Syst Rev; 2020 Oct; 10(10):CD002271. PubMed ID: 33058208 [TBL] [Abstract][Full Text] [Related]
14. Nebulised surfactant in preterm infants with or at risk of respiratory distress syndrome. Abdel-Latif ME; Osborn DA Cochrane Database Syst Rev; 2012 Oct; 10():CD008310. PubMed ID: 23076945 [TBL] [Abstract][Full Text] [Related]
15. Systemic corticosteroids for the prevention of bronchopulmonary dysplasia, a network meta-analysis. Hay S; Ovelman C; Zupancic JA; Doyle LW; Onland W; Konstantinidis M; Shah PS; Soll R Cochrane Database Syst Rev; 2023 Aug; 8(8):CD013730. PubMed ID: 37650547 [TBL] [Abstract][Full Text] [Related]
16. Caffeine dosing regimens in preterm infants with or at risk for apnea of prematurity. Bruschettini M; Brattström P; Russo C; Onland W; Davis PG; Soll R Cochrane Database Syst Rev; 2023 Apr; 4(4):CD013873. PubMed ID: 37040532 [TBL] [Abstract][Full Text] [Related]
17. Methylxanthine for the prevention and treatment of apnea in preterm infants. Marques KA; Bruschettini M; Roehr CC; Davis PG; Fiander M; Soll R Cochrane Database Syst Rev; 2023 Oct; 10(10):CD013830. PubMed ID: 37905735 [TBL] [Abstract][Full Text] [Related]
18. Inhaled versus systemic corticosteroids for preventing bronchopulmonary dysplasia in ventilated very low birth weight preterm neonates. Shah SS; Ohlsson A; Halliday HL; Shah VS Cochrane Database Syst Rev; 2017 Oct; 10(10):CD002058. PubMed ID: 29041034 [TBL] [Abstract][Full Text] [Related]
19. Systemic corticosteroid regimens for prevention of bronchopulmonary dysplasia in preterm infants. Onland W; van de Loo M; Offringa M; van Kaam A Cochrane Database Syst Rev; 2023 Mar; 3(3):CD010941. PubMed ID: 36912887 [TBL] [Abstract][Full Text] [Related]
20. Association of Noninvasive Ventilation Strategies With Mortality and Bronchopulmonary Dysplasia Among Preterm Infants: A Systematic Review and Meta-analysis. Isayama T; Iwami H; McDonald S; Beyene J JAMA; 2016 Aug; 316(6):611-24. PubMed ID: 27532916 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]